1. Home
  2. TCRT vs DGLY Comparison

TCRT vs DGLY Comparison

Compare TCRT & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • DGLY
  • Stock Information
  • Founded
  • TCRT 1998
  • DGLY 2004
  • Country
  • TCRT United States
  • DGLY United States
  • Employees
  • TCRT N/A
  • DGLY N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • TCRT Health Care
  • DGLY Technology
  • Exchange
  • TCRT Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • TCRT 3.8M
  • DGLY 2.4M
  • IPO Year
  • TCRT N/A
  • DGLY N/A
  • Fundamental
  • Price
  • TCRT $3.01
  • DGLY $0.06
  • Analyst Decision
  • TCRT
  • DGLY
  • Analyst Count
  • TCRT 0
  • DGLY 0
  • Target Price
  • TCRT N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • TCRT 49.8K
  • DGLY 88.9M
  • Earning Date
  • TCRT 05-19-2025
  • DGLY 05-20-2025
  • Dividend Yield
  • TCRT N/A
  • DGLY N/A
  • EPS Growth
  • TCRT N/A
  • DGLY N/A
  • EPS
  • TCRT N/A
  • DGLY N/A
  • Revenue
  • TCRT $10,000.00
  • DGLY $19,650,802.00
  • Revenue This Year
  • TCRT $5,680,500.00
  • DGLY N/A
  • Revenue Next Year
  • TCRT N/A
  • DGLY N/A
  • P/E Ratio
  • TCRT N/A
  • DGLY N/A
  • Revenue Growth
  • TCRT 100.00
  • DGLY N/A
  • 52 Week Low
  • TCRT $1.31
  • DGLY $0.04
  • 52 Week High
  • TCRT $14.20
  • DGLY $65.80
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 60.22
  • DGLY 22.10
  • Support Level
  • TCRT $2.56
  • DGLY $0.04
  • Resistance Level
  • TCRT $2.91
  • DGLY $1.00
  • Average True Range (ATR)
  • TCRT 0.28
  • DGLY 0.11
  • MACD
  • TCRT 0.02
  • DGLY -0.01
  • Stochastic Oscillator
  • TCRT 100.00
  • DGLY 2.10

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: